Venus Concept Regains Compliance with Nasdaq’s Minimum Equity Requirement
June 06, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that on June 4, 2024, it was...
Venus Concept Announces Approval for Venus Versa Pro in Canada
June 03, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a...
Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction
May 28, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that, on May 24, 2024,...
Venus Concept Announces First Quarter of Fiscal Year 2024 Financial Results
May 15, 2024 07:00 ET
|
Venus Concept Inc.
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the...
Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing
April 24, 2024 16:05 ET
|
Venus Concept Inc.
TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that on April 23,...
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
April 15, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of...
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
April 08, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, April 08, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received...
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
April 03, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has...
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
April 01, 2024 07:00 ET
|
Venus Concept Inc.
TORONTO, April 01, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the...
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
March 25, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO) announced today that it received a decision from the Nasdaq Hearings Panel (the...